Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
Featured
Page 2
Featured
Featured posts
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
BridgeBio’s BEYONTTRA approved by European Commission to treat ATTR-CM
UK unveils funding for AI companies to transform cancer care and spark new drug breakthroughs
Jabil acquires Pharmaceutics International, Inc.
5th February 2025
U.S. FDA approves Vertex’s JOURNAVX for adults with moderate-to-severe acute pain
5th February 2025
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for...
5th February 2025
U.S. FDA approves Celltrion’s AVTOZMA, a biosimilar to ACTEMRA
4th February 2025
hVIVO signs RSV human challenge trial contract with Inhalon Biopharma
4th February 2025
Sarclisa becomes first anti-CD38 treatment approved in China for patients with...
3rd February 2025
RYSTIGGO, for generalized myasthenia gravis, receives EU approval for two new...
3rd February 2025
Orion and Invenra to develop innovative bispecific antibody cancer therapeutics
3rd February 2025
FDA approves Ozempic to reduce risk of worsening kidney disease and...
30th January 2025
Beacon granted FDA Regenerative Medicine Advanced Therapy designation for X-linked retinitis...
30th January 2025
1
2
3
...
146
Page 2 of 146
News
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
AbbVie and Xilio Therapeutics, a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, have announced a collaboration and...
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
14th February 2025
The Duchenne muscular dystrophy (DMD) market across the seven major markets (7MM*) is set to grow from $2.3 billion in 2023 to $5.2 billion...
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
13th February 2025
Royalty Pharma has entered into an agreement with Biogen to provide research and development (R&D) funding of up to $250 million for litifilimab, a...